한글목차

Drug Discovery 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 1,241억 1,000만 달러에서 2026년에는 1,425억 4,000만 달러로, CAGR 14.8%로 성장할 것으로 예상됩니다. 지금까지의 성장은 만성질환 및 감염성 질환의 증가, 분자생물학 기술의 발전, 제약기업의 연구개발비 증가, 바이오테크놀러지 분야에서의 공동 연구 확대, 연구자금 확보 등이 주요 요인으로 꼽힙니다.

Drug Discovery 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 2,505억 1,000만 달러에 달하고, CAGR은 15.1%가 될 전망입니다. 예측 기간의 성장 요인으로는 AI 기반 Drug Discovery 플랫폼의 등장, 맞춤형 의료의 확대, 신약 설계에 오믹스 데이터 통합, 바이오의약품 아웃소싱의 성장, 실험실에서 자동화 및 로봇 기술 도입 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 하이스루풋 스크리닝 기술의 발전, 표적지향적 Drug Discovery, 맞춤형 의료 접근법, 약리유전체학의 통합, 나노기술을 활용한 Drug Discovery 등이 있습니다.

향후 몇 년 동안 의료비 지출 증가가 Drug Discovery 시장의 성장을 견인할 것으로 예상됩니다. 전 세계적으로 각국은 GDP의 상당 부분을 헬스케어(병원 의료, 의사 및 임상 서비스, 치과 서비스, 주택 및 개인 관리, 재택 의료, 요양 시설, 노인 주택, 처방약 등)에 투자하고 있습니다. Drug Discovery은 질병 치료제 개발 및 평균수명 연장에 필수적이기 때문에 이 지출의 주요 구성요소를 차지하고 있습니다. 신흥 질환에 대응하는 신약에 대한 수요 증가는 이러한 추세를 더욱 가속화시키고 있습니다. 예를 들어, 2024년 10월 미국 연방정부 기관인 메디케어-메디케이드 서비스 센터가 발표한 바에 따르면, 2022년 국내 의료비는 4.1% 증가하여 4조 5,000억 달러(1인당 1만 3,493달러)에 달할 것으로 예상했습니다. 2023년부터 2032년까지 국민 보건의료 의료비 평균 성장률(5.6%)은 GDP 성장률(4.3%)을 상회할 것으로 예상되며, GDP 대비 보건의료 의료비 비중은 2022년 17.3%에서 2032년 19.7%로 상승할 것으로 전망됩니다. 따라서 증가하는 헬스케어 의료비 증가가 Drug Discovery 시장 확대를 뒷받침하고 있습니다.

Drug Discovery 시장의 주요 기업들은 인공지능(AI), 이미징 기술 등 신기술을 도입하여 의약품 개발에 필요한 기간을 단축하고 있습니다. 이미징 기술은 생물이 약물에 반응할 때 발생하는 생물학적 활성을 비침습적으로 시각화, 특성화, 정량화할 수 있습니다. 프로브 또는 조직 특성을 활용하는 이러한 기술은 질병을 이해하고 새로운 치료법을 개발하는 데 있어 매우 중요합니다. 예를 들어, 2023년 5월 구글 클라우드는 Drug Discovery과 정밀의료를 가속화하기 위해 AI를 활용한 두 가지 툴인 '타겟 및 리드 식별 스위트'와 '멀티오믹스 스위트'를 발표했습니다. 타겟 및 리드 식별 제품군은 아미노산과 단백질의 기능적 이해를 돕고, 멀티오믹스 제품군은 유전체 데이터의 발견과 분석을 가속화하여 정밀 치료법 설계를 촉진합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Drug discovery is the process of identifying biologically active compounds with the potential to become therapeutic agents. This process spans multiple phases, from ideation and development to regulatory approval. It is aimed at discovering new clinical drugs for the treatment of new, existing, and previously untreatable diseases.

The main types of drugs in the drug discovery market are small molecules and large molecules. Small molecules are low molecular weight drugs that can easily penetrate cells and are identified for their suitable properties for further development. The drug discovery process involves various stages, including target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. Key technologies used in drug discovery include high-throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics and pharmacogenetics, bioinformatics, metabolomics, nanotechnology, and others. Drug discovery finds applications across multiple therapeutic areas such as oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases, diabetes, respiratory diseases, and more. It is utilized by pharmaceutical companies, contract research organizations (CROs), and other end-users.

Tariffs have impacted the drug discovery market by increasing the cost of imported laboratory equipment, high-throughput screening tools, and biotechnology reagents, causing supply chain disruptions across pharmaceutical and biotech companies. The small molecule and large molecule drug discovery segments, particularly in North America and Europe, are most affected due to reliance on imported technologies. However, tariffs have encouraged local manufacturing of certain reagents and instruments, fostering innovation and cost optimization in domestic markets. Overall, while costs may rise short-term, regional self-reliance could drive long-term efficiency.

The drug discovery market research report is one of a series of new reports from The Business Research Company that provides drug discovery market statistics, including drug discovery industry global market size, regional shares, competitors with a drug discovery market share, detailed drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery industry. This drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug discovery market size has grown rapidly in recent years. It will grow from $124.11 billion in 2025 to $142.54 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rise in chronic and infectious diseases, advancements in molecular biology techniques, increase in r&d spending by pharmaceutical companies, growth in biotechnology collaborations, availability of research funding.

The drug discovery market size is expected to see rapid growth in the next few years. It will grow to $250.51 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to emergence of ai-driven drug discovery platforms, expansion of personalized medicine, integration of omics data in drug design, growth in biopharmaceutical outsourcing, adoption of automation and robotics in laboratories. Major trends in the forecast period include high-throughput screening advancements, targeted drug development, personalized medicine approaches, integration of pharmacogenomics, nanotechnology-enabled drug discovery.

Rising healthcare expenditure is expected to drive growth in the drug discovery market over the coming years. Globally, countries are allocating a significant portion of their GDP to healthcare, including hospital care, physician and clinical services, dental services, residential and personal care, home healthcare, nursing facilities, continuing care retirement communities, prescription drugs, and more. Drug discovery represents a major component of this spending, as it is essential for developing treatments for diseases and extending life expectancy. The growing need for new drugs to address emerging diseases further fuels this trend. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure grew 4.1% to $4.5 trillion in 2022, or $13,493 per person. Over 2023-2032, average national health expenditure growth (5.6%) is projected to outpace GDP growth (4.3%), raising healthcare spending as a share of GDP from 17.3% in 2022 to 19.7% in 2032. Therefore, increasing healthcare expenditures are supporting the expansion of the drug discovery market.

Key players in the drug discovery market are adopting new technologies, such as artificial intelligence (AI) and imaging technology, to shorten the time required for drug development. Imaging technology allows non-invasive visualization, characterization, and quantification of biological activities in organisms in response to drugs. These techniques, utilizing either probes or tissue properties, are critical for understanding diseases and developing new treatments. For instance, in May 2023, Google Cloud launched two AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, to accelerate drug discovery and precision medicine. The Target and Lead Identification Suite aids in understanding the function of amino acids and proteins, while the Multiomics Suite speeds up the discovery and analysis of genomic data, facilitating the design of precision therapies.

In July 2024, Iktos, a France-based pharmaceutical and biotech company, acquired Synsight for an undisclosed amount. The acquisition aims to strengthen Iktos's platform by integrating Synsight's advanced technologies, particularly the MT Bench(TM) system for high-performance screening of biological interactions. Synsight is a France-based biotechnology company.

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrodinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery market includes revenues earned by entities by high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics and pharmacogenetics, bioinformatics, metabolomics, and nanotechnology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Small Molecule; Large Molecule
• 2) By Process: Target Selection; Target Validation; Hit-To-Lead Identification; Lead Optimization; Candidate Validation
• 3) By Technology: High Throughput Screening; Spectroscopy; Combinatorial Chemistry; Biochips; Pharmacogenomics And Pharmacogenetics; Bioinformatics; Metabolomics; Nanotechnology; Other Technologies
• 4) By Therapeutic Area: Oncology; Neurology; Infectious And Immune System Diseases; Digestive System Diseases; Cardiovascular Diseases; Diabetes; Respiratory Disease; Other Therapeutic Areas
• 5) By End User: Pharmaceutical Companies; CROs; Other End-Users
• Subsegments:
• 1) By Small Molecule: Synthetic Small Molecules; Natural Small Molecules; Targeted Small Molecule Drugs
• 2) By Large Molecule: Monoclonal Antibodies; Proteins And Peptides; Nucleic Acid-Based Therapies
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis International AG; Thermo Fisher Scientific Inc.; WuXi AppTec Group; GlaxoSmithKline plc; Eli Lilly and Company; Laboratory Corporation of America Holdings; Evotec SE; Eurofins Scientific SE; Agilent Technologies Inc.; Sanofi S.A.; Charles River Laboratories International Inc.; Pharmaron Ltd.; Viva Biotech Ltd.; Albany Molecular Research Inc.; Schrodinger Inc.; BioDuro Ltd.; Aptuit LLC; Selvita S.A.; Sygnature Discovery Limited; Jubilant Biosys Limited; Gero Limited; Domainex Ltd.; Verge Genomics lnc.; Aqemia SAS; BenevolentAI Limited; EPIVAX INC.; ProteinQure lnc.; Synlogic Inc.; ChemPartner Co. Ltd.; WuXi Biologics lnc.; Abzena plc; Lonza Group Ltd.; Catalent lnc.; Recursion Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Drug Discovery Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Drug Discovery Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Drug Discovery Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Drug Discovery Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 High-Throughput Screening Advancements
  • 4.2.2 Targeted Drug Development
  • 4.2.3 Personalized Medicine Approaches
  • 4.2.4 Integration Of Pharmacogenomics
  • 4.2.5 Nanotechnology-Enabled Drug Discovery

5. Drug Discovery Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Contract Research Organizations (Cros)
• 5.3 Biotechnology Companies
• 5.4 Academic And Research Institutions
• 5.5 Diagnostic Laboratories

6. Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Discovery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Drug Discovery Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Drug Discovery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Drug Discovery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Discovery Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Discovery Market Segmentation

• 9.1. Global Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Small Molecule, Large Molecule
• 9.2. Global Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation
• 9.3. Global Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies
• 9.4. Global Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas
• 9.5. Global Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, CROs, Other End-Users
• 9.6. Global Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs
• 9.7. Global Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

10. Drug Discovery Market Regional And Country Analysis

• 10.1. Global Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Discovery Market

• 11.1. Asia-Pacific Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Discovery Market

• 12.1. China Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Discovery Market

• 13.1. India Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Discovery Market

• 14.1. Japan Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Discovery Market

• 15.1. Australia Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Discovery Market

• 16.1. Indonesia Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Discovery Market

• 17.1. South Korea Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Discovery Market

• 18.1. Taiwan Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Discovery Market

• 19.1. South East Asia Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Discovery Market

• 20.1. Western Europe Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Discovery Market

• 21.1. UK Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Discovery Market

• 22.1. Germany Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Discovery Market

• 23.1. France Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Discovery Market

• 24.1. Italy Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Discovery Market

• 25.1. Spain Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Discovery Market

• 26.1. Eastern Europe Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Discovery Market

• 27.1. Russia Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Discovery Market

• 28.1. North America Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Discovery Market

• 29.1. USA Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Discovery Market

• 30.1. Canada Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Discovery Market

• 31.1. South America Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Discovery Market

• 32.1. Brazil Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Discovery Market

• 33.1. Middle East Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Discovery Market

• 34.1. Africa Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Drug Discovery Market, Segmentation By Drug Type, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Discovery Market Regulatory and Investment Landscape

36. Drug Discovery Market Competitive Landscape And Company Profiles

• 36.1. Drug Discovery Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Drug Discovery Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Drug Discovery Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. WuXi AppTec Group Overview, Products and Services, Strategy and Financial Analysis

37. Drug Discovery Market Other Major And Innovative Companies

• GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrodinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A.

38. Global Drug Discovery Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Discovery Market

40. Drug Discovery Market High Potential Countries, Segments and Strategies

• 40.1 Drug Discovery Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Drug Discovery Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Drug Discovery Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer